Published in J Infect Dis on February 01, 2000
Immunogenicity and safety of diphtheria-tetanus vaccine in adults. J Korean Med Sci (2010) 0.80
Diphtheria, tetanus, and pertussis immunity in Indian adults and immunogenicity of td vaccine. ISRN Microbiol (2011) 0.75
A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med (1995) 4.21
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis. N Engl J Med (1995) 2.81
Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet (1996) 2.78
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24
Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev (2000) 2.06
Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00
Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.67
Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis (2000) 1.67
Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA (1996) 1.64
Estuary-associated syndrome in North Carolina: an occupational prevalence study. Environ Health Perspect (2001) 1.56
Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53
Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol (2001) 1.53
Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics (1995) 1.52
Vaccine-associated paralytic poliomyelitis. N Engl J Med (1993) 1.39
Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis (1998) 1.38
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med (1994) 1.23
Outbreaks of paralytic poliomyelitis, 1976-1995. J Infect Dis (1997) 1.20
Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis (2001) 1.20
Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. Pediatrics (1990) 1.18
Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Health Organ (2000) 1.18
Measles eradication: is it in our future? Am J Public Health (2000) 1.12
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
Tetanus surveillance--United States, 1989-1990. MMWR CDC Surveill Summ (1992) 1.09
Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics (1997) 1.03
Statewide adolescent asthma surveillance. J Asthma (2000) 1.01
Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Child (1992) 1.01
Vaccine-associated paralytic poliomyelitis and HIV infection. Lancet (1994) 1.00
Postexposure rabies prophylaxis with human rabies immune globulin. JAMA (1974) 0.99
Serologic evidence of subclinical pertussis in immunized children. Pediatr Infect Dis J (1990) 0.98
Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr (1993) 0.96
The effect of breast-feeding on the antibody response of infants to trivalent oral poliovirus vaccine. J Pediatr (1973) 0.96
Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough. Clin Infect Dis (1995) 0.95
A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan. Vaccine (2013) 0.90
Tetanus surveillance--United States, 1991-1994. MMWR CDC Surveill Summ (1997) 0.89
Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis. Infect Immun (1994) 0.88
Human visual function in the North Carolina clinical study on possible estuary-associated syndrome. J Toxicol Environ Health A (2001) 0.88
Outbreak of poliomyelitis in Gizan, Saudi Arabia: cocirculation of wild type 1 polioviruses from three separate origins. J Infect Dis (1997) 0.83
Response to measles-mumps-rubella vaccine in children on dialysis. Pediatr Nephrol (1992) 0.83
Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants. Vaccine (2001) 0.83
Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines. Pediatrics (1995) 0.82
Commentary: the unfolding story of global poliomyelitis eradication. J Infect Dis (1997) 0.82
Using cost-effectiveness analysis to evaluate targeting strategies: the case of vitamin A supplementation. Health Policy Plan (1997) 0.82
Status of poliomyelitis eradication in Europe and the Central Asian republics of the former Soviet Union. J Infect Dis (1997) 0.81
Immunogenicity of tetanus-diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union. J Infect Dis (2000) 0.80
Widespread paralytic poliomyelitis in Pakistan: A case-control study to determine risk factors and implications for poliomyelitis eradication. J Infect Dis (2000) 0.80
Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994. J Infect Dis (1997) 0.80
Immunization response varies with intensity of acute lymphoblastic leukemia therapy. Am J Dis Child (1991) 0.80
Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance. J Infect Dis (1997) 0.79
Stopping a polio outbreak in the post-eradication era. Dev Biol (Basel) (2001) 0.78
Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant (1996) 0.78
Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months. Int J Epidemiol (1994) 0.78
Epidemic diphtheria in the Republic of Georgia, 1993-1996: risk factors for fatal outcome among hospitalized patients. J Infect Dis (2000) 0.78
Response of human immunodeficiency virus-infected adults to measles-rubella vaccination. J Acquir Immune Defic Syndr (1993) 0.77
Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric renal transplant recipients. Am J Nephrol (1997) 0.77
Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine. Biologicals (1998) 0.77
Dose-response to acellular pertussis vaccine and comparison with whole cell pertussis vaccine at 15-24 months and 4-6 years of age. Acellular Pertussis Vaccine Study Team. Vaccine (1992) 0.76
Vaccine-associated paralytic poliomyelitis in the United States: no evidence of elevated risk after simultaneous intramuscular injections of vaccine. Pediatr Infect Dis J (1995) 0.76
Outbreak of vertigo in Wyoming: possible role of an enterovirus infection. Epidemiol Infect (1996) 0.75
Response to the varicella vaccine in children with nephrotic syndrome. J Pediatr (1997) 0.75
Measles immunization in HCWs. Infect Control Hosp Epidemiol (1994) 0.75
Tetanus immunization: concerns about the elderly and about diphtheria reemergence. J Gen Intern Med (1994) 0.75
Immunity to diphtheria in a sample of the Canadian adult population. Can J Infect Dis (1998) 0.75
Tetanus immune status of adult patients in an urban family practice. J Fam Pract (1986) 0.75
Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines. Pediatrics (1995) 0.75
Risk factors for diphtheria: a prospective case-control study in the Republic of Georgia, 1995-1996. J Infect Dis (2000) 0.75
Charcoal as a carrier in a rapid slide agglutination test for the detection of antibodies to adenoviruses. J Immunol (1967) 0.75
Letter: Failure of measles vaccination. J Pediatr (1973) 0.75
Trimethoprim-sulfamethoxazole in the treatment of typhoid and paratyphoid fevers. J Infect Dis (1973) 0.75
Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions. J Infect Dis (2000) 0.75
Immunogenicity of high-titer Edmonston-Zagreb measles vaccine in human immunodeficiency virus-infected children in Kinshasa, Zaire. J Infect Dis (1993) 0.75
Possible global strategies for stopping polio vaccination and how they could be harmonized. Dev Biol (Basel) (2001) 0.75
Impact of treatment guidelines on use of ribavirin. Am J Dis Child (1990) 0.75
Poliomyelitis in Angola: current status and implications for poliovirus eradication in Southern Africa. J Infect Dis (1997) 0.75
Georgia's public-health problems. Lancet (1997) 0.75